1996
(BETA) Open Clinical Trials for HIV/AIDS Treatments Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Leslie Hanna (BETA) More Good News on Combination Therapy Using Protease Inhibitor Drugs Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Ron Baker, Ph.D. (BETA) Internation AIDS Society-USA Releases Treatment Guidelines for HIV/AIDS Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Harvey S. Bartnof, MD (BETA) Research Notes Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Harvey S. Bartnof, MD, and Henry E. Chang (BETA) WOMEN AND HIV: Perinatal HIV Transmission Prevention Strategies: an Economic Perspective Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Leslie Hanna (BETA) WOMEN AND HIV: Perinatal HIV Transmission in the Era of 076: Updates from the XI International Conference on AIDS in Vancouver, BC Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Leslie Hanna (BETA) Blood Test Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Mark Bowers (BETA) AIDS Dementia Complex Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Mark Bowers (BETA) Mycobacterium avium Complex Disease: Clinical Updates Bulletin of Experimental Treatments for AIDS, No. 31; December, 1996 Leslie Hanna (BETA) News Briefs Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Mark Bowers (BETA) New Patient Assistance Programs for HIV Viral Load Testing Bulletin of Experimental Treatments for AIDS, No. 31, December 1996
(BETA) AIDS Treatment Advocacy Issues Bulletin of Experimental Treatments for AIDS, No. 31, December 1996 Ron Baker, PhD (BETA) The Options Project Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Leslie Hanna (BETA) Open Clinical Trials for HIV/AIDS Treatments Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Leslie Hanna (BETA) Women and HIV/AIDS: Critical Issues in Treating HIV During Pregnancy Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Ellen J. Landsberger, MD (BETA) HIV Vaccines Bulletin of Experimental Treatments for AIDS, No. 30; June, 1996 Mark Bowers (BETA) Anabolic Steroids in the Treatment of HIV-related Wasting Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Mark Bowers (BETA) Highlights from the XI International Conference on AIDS Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Harvey S. Bartnof, MD, Leslie Hanna and Liz Highleyman (BETA) Impressions from Vancouver Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Ronald Baker, PhD (BETA) Advocacy: The HMO Patients' Rights Act Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Ronald Baker, PhD (BETA) Advocacy: The Case for Medical Marijuana: Vote Yes on Proposition 215 Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Ronald Baker, PhD (BETA) Advocacy: Access to HIV Viral Load Testing Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Ronald Baker, PhD (BETA) News Briefs Bulletin of Experimental Treatments for AIDS, No. 30; September, 1996 Mark Bowers, Managing Editor of BETA. (BETA) WOMEN AND AIDS: Cervical Cancer Screening Issues for HIV Positive Women: A Physician's Perspective Bulletin of Experimental Treatments for AIDS, No. 29; June, 1996 Lisa Bardaro, MD (BETA) HIV/AIDS in Children: Overview and Guidelines for Disease Management Bulletin of Experimental Treatments for AIDS, No. 29; June, 1996 Leslie Hanna, Associate Editor of BETA. (BETA) Non-Nucleoside Reverse Transcriptase Inhibitors Bulletin of Experimental Treatments for AIDS, No. 29; June, 1996 Mark Bowers, Managing Editor of Treatment Publications at the San Francisco AIDS Foundation. (BETA) Pneumonia Bulletin of Experimental Treatments for AIDS, No. 29; June, 1996 Bruce Mirken, freelance writer based in San Francisco. (BETA) HIV Viral Load Supercedes CD4 Count as Best Marker for Predicting Risk of AIDS and Death Bulletin of Experimental Treatments for AIDS, No. 29; June, 1996 Ronald Baker, PhD, Editor-in-Chief of BETA and Director of Treatment Education and Advocacy at the San Francisco AIDS Foundation. (BETA) New Briefs Bulletin of Experimental Treatments for AIDS, No. 29; June, 1996 BETA Editorial Staff (BETA) Scope and Limitations of Gene Therapy for HIV Infection Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Henry E. Chang and Mark Bowers (BETA) AIDS Fraud Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Mark Bowers, Managing Editor of Treatment Publications at the San Francisco AIDS Foundation. (BETA) News Briefs Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Mark Bowers, Managing Editor of Treatment Publications and a member of the Scientific Advisory Committee of the San Francisco AIDS Foundation. (BETA) Research Notes Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Mark Bowers, Managing Editor of Treatment Publications at the San Francisco AIDS Foundation. (BETA) Pelvic Inflammatory Disease Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Liz Highleyman and Leslie Hanna (BETA) Kaposi's Sarcoma Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Harvey S. Bartnof, MD; Member of the Scientific Advisory Committee at the San Francisco AIDS Foundation since 1987. He has been Course Director of "AIDS-HIV: Overview and Update" at the University of California at San Francisco School of Medicine since 1985. (BETA) Report from the 3rd Conference on Retroviruses and Opportunistic Infections Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Mary Romeyn, MD; Member of the San Francisco AIDS Foundation's Scientific Advisory Board. (BETA) Highlights From the FDA Antiviral Drugs Advisory Committee Meetings, 2/27 - 3/1, 1996 Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Ronald Baker, PhD; Editor-in-Chief of BETA and Director of Treatment Education and Advocacy at the San Francisco AIDS Foundation. Guest member of the FDA review panel for Abbott's protease inhibitor drug ritonavir. (BETA) Avoiding Cryptosporidium: Safe Food, Safe Water, Safe Sex Bulletin of Experimental Treatments for AIDS, No. 28; March, 1996 Diane Cenko, Volunteer on the Project Inform Treatment Hotline and a director of the Andrew Ziegler Foundation. Copyright © 1996 - San Francisco AIDS Foundation. Reproduced by permission. Reproduction of this article (other than one copy for personal reference) must be cleared through BETA: PO Box 426182, San Francisco, CA 94142-6182. Tel: 415 487 8060 Fax: 415 487 8069 URL: http://www.sfaf.org/beta E-mail: beta@sfaf.org
This information is designed to support, not replace, the relationship that exists between you and your doctor. 
This information is designed to support, not replace, the relationship that exists between you and your doctor.